Lately, two Phase III clinical trials of a combination treatment of two drugs that inhibit different parts of the HIV virus have exhibited heartening results. HIV diagnosis is no more a death sentence and now people taking treatment survive for decades with the disease. For more than 15 years, the first line of therapy has been a suite of antiretroviral drugs in pill form, taken once a day. Although this treatment has transformed HIV from a certain killer to chronic disease in much of the developed world, there are problems. Recently, ViiV Healthcare released data from two Phase III clinical trials of a combination treatment of two drugs ¬that inhibit different parts of the virus.
This news content is a computer generated summarized version of the original article and the authenticity of the original content has not been verified. Please click on the View Article button to refer to the actual content.